EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer

Prabhat Kumar, Shilpi Gupta, Bhudev C Das

Translational Oncology · 2024-02 · 40 · 101827

DOI: 10.1016/j.tranon.2023.101827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-02. Verfasst von Prabhat Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, …. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 251 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinomas (HNSCCs) are the most devastating diseases in India and southeast Asia. It is a preventable and curable disease if detected early. Tobacco and alcohol consumption are the two major risk-factors but infection of high-risk HPVs are also associated with development of predominantly oral and oropharyngeal carcinomas. Interestingly, unlike cervical cancer, HPV-induced HNSCCs show good prognosis and better survival in contrast, majority of tobacco-associated HPV-ve HNSCCs are highly aggressive with poor clinical outcome. Biomarker analysis in circulatory body-fluids for early cancer diagnosis, prognosis and treatment monitoring are becoming important in clinical practice. Early diagnosis using non-invasive saliva for oral or other diseases plays an important role in successful treatment and better prognosis. Saliva mirrors the body's state of health as it comes into direct contact with oral lesions and needs no trained manpower to collect, making it a suitable bio-fluid of choice for screening. Saliva can be used to detect not only virus, bacteria and other biomarkers but variety of molecular and genetic markers for an early detection, treatment and monitoring cancer and other diseases. The performance of saliva-based diagnostics are reported to be highly (≥95 %) sensitive and specific indicating the test's ability to correctly identify true positive or negative cases. This review focuses on the potentials of saliva in the early detection of not only HPV or other pathogens but also identification of highly reliable gene mutations, oral-microbiomes, metabolites, salivary cytokines, non-coding RNAs and exosomal miRNAs. It also discusses the importance of saliva as a reliable, cost-effective and an easy alternative to invasive procedures.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerEarly detectionHPV screeningHead and neck cancerLiquid biopsyNon-invasiveSaliva

Autor:innen und Institutionen

  • Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida 201313, India.
  • Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida 201313, India. Electronic address: bcdas@amity.edu.

Zitieren

APA

Kumar, P., Gupta, S., & Das, B. C. (2024). Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer. Translational Oncology, 40, 101827. https://doi.org/10.1016/j.tranon.2023.101827

Vancouver

Kumar P, Gupta S, Das BC. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer. Translational Oncology. 2024;40:101827. doi:10.1016/j.tranon.2023.101827

BibTeX
@article{Kumar2024,
  author = {Kumar, Prabhat and Gupta, Shilpi and Das, Bhudev C},
  title = {Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer},
  journal = {Translational Oncology},
  year = {2024},
  volume = {40},
  pages = {101827},
  doi = {10.1016/j.tranon.2023.101827}
}
Kostenlos starten →